The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches

By Hu Chi-Tan   Wu Jia-Ru   Cheng Chuan-Chu   Wu Wen-Sheng  

Cancers, Vol. 9, Iss. 6, 2017-05 ,pp. : 58-58

MDPI

Access to resources Recommend Favorite

Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway

By            

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 651-658

Spandidos Publications

Access to resources Recommend Favorite

Differential role of MACC1 expression and its regulation of the HGF/cMet pathway between breast and colorectal cancer

By                

International Journal of Oncology, Vol. 46, Iss. 5, 2015-01 ,pp. : 2143-2153

Spandidos Publications

Access to resources Recommend Favorite

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma

By Cruickshanks Nichola   Zhang Ying   Yuan Fang   Pahuski Mary   Gibert Myron   Abounader Roger  

Cancers, Vol. 9, Iss. 7, 2017-07 ,pp. : 87-87

MDPI

Access to resources Recommend Favorite

Inhibition of HGF/cMET expression prevents distant recurrence of rectal cancer after preoperative chemoradiotherapy

By Saigusa Susumu   Toiyama Yuji   Tanaka Koji   Yokoe Takeshi   Fujikawa Hiroyuki   Matsushita Kohei   Okugawa Yoshinaga   Inoue Yasuhiro   Uchida Keiichi   Mohri Yasuhiko   Kusunoki Masato  

International Journal of Oncology, Vol. 40, Iss. 2, 2012-02 ,pp. : 583-591

Spandidos Publications

Access to resources Recommend Favorite